CDKN2B and laryngotracheoesophageal cleft: This verifies the targeted regulatory association of CDKN2B-AS1 with miR-199a-5p again and also implies that we can treat LC by suppressing CDKN2B-AS1 and improving the autophagy of LC cells in the future.